in view of the intended use of maturation induction treatment as an alternative to current antileukemic therapy it appeared to be of interest to know if granulocytes , obtained by ra treatment of the promyelocytic leukemia cell line hl-60 , would produce normal hp or if their transformed phenotype would cause production of deviant regulatory peptide ( s ) .
C0040845
ra
C0023487
promyelocytic